Cosmos Health's Subsidiary Cana Laboratories Secures Additional Contract Manufacturing Agreements With Provident Pharmaceuticals; Provident Focuses On Niche And Legacy Pharmaceutical Products And Medical Devices

Specifically, Cana secured additional orders to manufacture the following medicines:

408,000 units of MIOREL, used to reduce and relieve excessive muscle spasms, commonly seen in conditions like multiple sclerosis, diseases, or spinal cord injuries;

222,000 units of CALCIFOLIN, an active metabolite of folic acid necessary for nucleic acid synthesis during cytotoxic therapy;

72,000 units of DEXA-DOSE, a synthetic glucocorticoid with potent anti-inflammatory properties, also used for its anti-allergic, anti-toxic, antipyretic, and immunosuppressive effects.